Every day that Congress fails to act needlessly jeopardizes the livelihood of these small businesses and their consumers.
The U.S. 11th Circuit Court of Appeals has accepted NORML’s ‘friend of the court’ amicus brief in a case that seeks to protect the Second Amendment rights of state-authorized medical cannabis patients.
Highlights include LA, ME, MD, MN, MT, NV, NH, NY, OH, PA, and RI.
Federal law enforcement agents and their partners seized nearly 5.7 million cultivated marijuana plants in 2022. This is the highest annual seizure total reported by the agency since 2011.
“In [this] cohort of ever-tobacco smokers of ≥20 pack-years with established COPD or at risk of developing COPD, … a history of current and/or former smoking of marijuana of any cumulative lifetime amount was not found to be associated with a significantly deleterious impact on progression of COPD.”
“Policies that mandate would-be hires to undergo urine screens for past cannabis exposure are invasive, discriminatory, and ineffective. They neither identify workers who may be under the influence, nor do they contribute to a safe work environment.”
Provisions in the bill permit adults to purchase (up to two ounces from state-licensed retailers and/or 8 grams of concentrate and 800 milligrams worth of edible products), home-cultivate (up to eight plants, no more than four of which can be mature), and possess cannabis (up to 2 pounds in private).
After a century of failed policies and canna-bigotry, Americans are ready to move in a different direction — one that legalizes, regulates, and educates.